Machine Learning-Based Identification of High-Risk Patterns in Atrial Fibrillation Ablation Outcomes

Abstract

Background Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmias, often leading to serious health issues such as stroke, heart failure, and higher mortality rates. Its global impact is rising due to aging populations and growing comorbidities, creating an urgent need for more effective treatment methods. AF ablation, a key treatment option, has success rates that vary widely among patients. Conventional predictors of ablation outcomes, which primarily rely on sociodemographic and clinical factors, fall short of capturing the heterogeneity within patient populations, highlighting the potential for data-driven methods to provide deeper insights into procedural success. Objectives To uncover meaningful patient subgroups based on AF ablation outcomes and identify diagnostic codes associated with failure. Methods Machine learning clustering with must-link and cannot-link constraints was applied to electronic health records to discover meaningful clusters, revealing patient-specific factors influencing procedural success or failure. Statistical analyses, including chi-square tests, were used to identify diagnostic codes significantly associated with ablation failure. Results Out of the 145 diagnostic codes examined, thirteen significant codes were identified and categorized into four primary risk groups, ranked by their impact on procedural outcomes: (1) direct contributors affecting cardiovascular health, (2) indirect factors that contribute to systemic stress, (3) complications related to anticoagulation and hemorrhagic risks that can impact bleeding management, and (4) broader health indicators reflecting a general health burden that reduce patients resilience to procedural stress. Conclusions This study shows the importance of cardiovascular and non-cardiovascular factors in AF ablation outcomes, emphasizing the need for a more comprehensive pre-procedural evaluation. It also contributes to the application of machine learning in personalized risk assessment for AF and advancing individualized care strategies that may improve ablation success.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the National Institute of Health / National Heart, Lung, and Blood Insitute award R21HL156184.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Emory University's Institutional Review Board waived ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

留言 (0)

沒有登入
gif